IVBT OTC
Innovation1 Biotech Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$53K
+97.9% ▲
Operating Income
-$1M
+74.0% ▲
Net Income
-$6M
+85.4% ▲
EPS (Diluted)
$-0.70
+74.4% ▲
EBITDA
-$6M
+85.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $79K | $1K | $3K | $0 | $0 |
| YoY Growth | +372.5% | -98.5% | +160.8% | -100.0% | +0.0% |
| Cost of Revenue | $129K | $3K | $1K | $3M | $53K |
| Gross Profit | -$50K | -$2K | $2K | -$3M | -$53K |
| Gross Margin | -63.2% | -151.0% | 53.9% | — | — |
| R&D Expenses | $0 | $0 | $0 | $201K | $15K |
| SG&A Expenses | $617K | $215K | $241K | $3M | $1M |
| Operating Expenses | $617K | $215K | $241K | $3M | $1M |
| Operating Income | -$627K | -$217K | -$258K | -$5M | -$1M |
| Operating Margin | -791.2% | -18374.3% | -8390.9% | — | — |
| Interest Expense | $587 | $1M | $220K | $6K | $252K |
| Income Before Tax | -$170K | -$3M | $1M | -$41M | -$6M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$170K | -$3M | $1M | -$41M | -$6M |
| Net Margin | -214.5% | -218458.9% | 33766.2% | — | — |
| EPS (Diluted) | $-0.39 | $-8.59 | $5.53 | $-2.73 | $-0.70 |
| EBITDA | -$168K | -$1M | $1M | -$38M | -$6M |
| Shares Outstanding | 436039 | 300261 | 188094 | 15M | 20M |